Loading...
Loading...
Browse all stories on DeepNewz
VisitWill the FDA approve a new lupus treatment based on the molecular defect discovery by July 11, 2025?
Yes • 50%
No • 50%
FDA official announcements or press releases
Discovery of Immune Defect by Chicago Researchers Could Lead to Lupus Cure
Jul 11, 2024, 01:00 AM
Researchers have identified a molecular defect in the immune system that may be the root cause of lupus, a life-threatening condition. This discovery, described as a 'molecular switch' or 'naturally occurring seesaw,' could potentially reverse the harmful immune response and lead to new treatments or a cure for the autoimmune disorder. The breakthrough was made by scientists from Northwestern Medicine, Brigham and Women's Hospital, and Chicago researchers, pointing to a future where the immune cells driving lupus damage could be turned into beneficial cells, thereby saving tissue and preventing the immune system from attacking the body.
View original story
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Clinical hold • 25%
No action • 25%
Request for additional data • 25%
Other • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Breakthrough Therapy • 25%
No designation • 25%
Orphan Drug • 25%
Fast Track • 25%
Partial success in Phase 1 • 25%
No results announced • 25%
Successful completion of Phase 1 • 25%
Failure in Phase 1 • 25%